{"id":707171,"date":[{"year":1985,"month":8,"day":29}],"page":"2","source":"本报","region":"","masthead":"","special_issue":"","column":"","genre":"","count":"241","ytitle":"","mtitle":"大面积放射治疗何杰金氏病 十年生存率达国际先进水平","ftitle":"","authors":["夏孝勋"],"text":[{"type":"paragraph","text":"本报讯　上海医科大学肿瘤医院放射治疗科在国内首先采用大面积放射治疗何杰金氏病取得显著疗效，据统计，一、二期的十年生存率为百分之八十五，达到国际先进水平。"},{"type":"paragraph","text":"何杰金氏病是发生在淋巴系统的恶性肿瘤。过去对一、二期病员作放射治疗时，只照射局部肿大的淋巴结。所以，五年生存率仅百分之四十，近年来，他们自行设计制造了大面积放射治疗的工具，对一、二期病员进行次全淋巴结或全淋巴结照射，这样能照射多处的肿瘤病灶，保护了避免照射的重要脏器。　(夏孝勋)"}]}